§ 27-18-49 - Human leukocyte antigen testing.
SECTION 27-18-49
§ 27-18-49 Human leukocyte antigentesting. – (a) Every individual or group hospital or medical services plan contractdelivered or renewed in this state shall include coverage of the cost for humanleukocyte antigen testing, also referred to as histocompatibility locus antigentesting, for A, B, and DR antigens for utilization in bone marrowtransplantation. The testing must be performed in a facility that is accreditedby the American Association of Blood Banks or its successors, and is licensedunder the Clinical Laboratory Improvement Act, 42 U.S.C. § 263a, as it maybe from time to time amended. At the time of the testing, the person beingtested must complete and sign an informed consent form that also authorizes theresults of the test to be used for participation in the National Marrow DonorProgram. The group hospital or medical services plan contract may limit eachsubscriber to one of these testings per lifetime.
(b) This section shall not apply to insurance coverageproviding benefits for: (1) hospital confinement indemnity; (2) disabilityincome; (3) accident only; (4) long term care; (5) Medicare supplement; (6)limited benefit health; (7) specified disease indemnity; (8) sickness or bodilyinjury or death by accident or both; and (9) other limited benefit policies.